Tuesday, October 6, 2020

India Domestic Pumps (Less than 2.5 HP) Market Outlook to 2025: Ken Research

The report titled India Domestic Pumps (Less than 2.5 HP) Market Driven by Depleting Ground Water Level and Rise in the Number of Infrastructure Projects" provides a comprehensive analysis of Domestic Pump Market (Less than 2.5 HP) in India. The report covers overview and genesis of the industry, overall market size in terms of revenue and sales volume, market segmentation by market structure, pump type, motor rating, states and by distribution channel; porter five forces analysis, trends and developments, issues and challenges, government regulations, smart  city analysis and competition landscape including competition scenario, cross comparison, strengths, weaknesses and company profiling of major players in Domestic Pump Market (Less than 2.5 HP) in India. The report concludes with future market projections on the basis of revenue and sales volume, and future market segmentation by market structure, pump type, motor rating, and states and by distribution channel and analyst recommendations highlighting the major opportunities and cautions in the industry.

Market Overview (Demand and Supply Scenario)

India Domestic Pump Market grew at CAGR of 4-6% during the review period FY’2015-FY’2020. Depleting ground water level, rapid urbanization and rise in the number of infrastructure initiatives are some of major factors responsible for the surge in demand for domestic pumps (Less than 2.5 HP).  Coimbatore, Rajkot, Ahmednagar, Kolhapur have been the major manufacturing hubs for domestic pumps (Less than 2.5 HP) in India. In-house manufacturing, procurement from contract manufacturers and imports have been primarily three strategies adopted by companies in India Domestic Pump Market.

Each company has multiple dealers scattered across the country who partner with retailers for making the products available to the customers. Dealers are responsible for stocking up products and maintaining professional relationship with the retailers. They maintain a stock of 2-3 months depending upon the location and the company.  Sales Volume and Revenue, Market Coverage, Product Range, Margin Sharing and Storage Unit/Warehouse have been some of the factors taken into consideration before empanelling a dealer.

India Domestic Pumps Market Segmentation

By Market Structure (Organized and Unorganized Market)

Total Domestic Pump Market in India has been dominated by organized players, followed by unorganized players. Unorganized Players are scattered across the country. Although majority of the players are present in Coimbatore and Rajkot. The unorganized players offer products at a low price and offer replacement warranty of 12-24 months in contrast to organized players who offer a repair warranty of 12-24 months. This has placed immense pressure on organized players in terms of cost and maintaining the quality of the product at the same time, squeezing their overall margins.

By Pump Type & Motor Rating

Major pumps demanded in India in domestic pump category are Mini Monoblock Pumps, Borewell Submersible Pumps, Pressure Booster Pumps and Others. 0.5-1 HP and 1-1.5 HP is the most demanded product category in domestic pump category. Average price range for domestic pumps sold in India is between INR 4,000-12,000. CRI Pumps, KSB, Texmo, Aquatex, Lubi, Varuna Pumps and V Guard have been the leading players in the product categories mentioned above. Upcoming regions for domestic pump in India are Maharashtra, UP, Bihar, West Bengal and other Metropolitan cities.

By States

The demand for domestic pumps (Less than 2.5 HP) was dominated by Maharashtra, Karnataka, Telangana, Gujarat, Tamil Nadu, Kerala, Delhi NCR, West Bengal, Madhya Pradesh and Bihar. Texmo Industries, CRI Pumps, V-Guard, Aqua Group are the leading players in South region.

By Distribution Channel

Major players in domestic pump market follow multiple channels of making the products available to the end users including dealers and distributor, direct sales and online channel. Dealer and distribution channel dominated the sales for domestic pumps in India followed by direct channel and online channel. Major companies have more than 1,000 channel partners scattered across the country for distribution of products.

Competitive Landscape

The total domestic pump market in India is highly fragmented in nature with more than 300 brands of organized and unorganized pumps available in the market. In addition to this, organized pump market in India is moderately concentrated among top 10 players, capturing more than 80% market share basis revenue. Product Performance, Price, Product Range, Warranty, Brand Name, After Sale Service, Distributor Network, Marketing Communication, Product Life  Services have been mapped as mapped as major competing parameters for companies operating in India Domestic Pump Market. Companies with large product range, wide regional presence and effective after sale services are indentified as clear leaders in the industry.

Impact of COVID-19

Domestic Pump Industry in India witnessed a decline in pump sales during the pandemic, owing to retail stores being closed and no construction activity happening in the country. Companies increased their manufacturing capacity utilization to cover the loss in domestic pump sales during Quarter 1 and Quarter 2. In addition to this, social distancing norms and regular medical checkups were performed at the manufacturing plant and office to ensure safety of workers.

Future Outlook and Projection

The demand is expected to grow with a CAGR of 2.4% and 1.1% on the basis of revenue and sales volume respectively, during the forecast period. Due to ever increasing concern of saving energy, companies are expected to increase the production of energy efficient pumps. In addition to this, rise in demand for smart pumps, depleting ground water level and rise in household construction to drive the domestic pump market (less than 2.5 HP) in India.

Key Segments Covered:-

By Market Structure

Organized Market

Unorganized Market

By Pump Type

Mini Monoblock Pumps

Borewell Submersible Pumps

Pressure Booster Pumps

Other Pumps

By Motor Rating

0.5 HP

0.5-1.0 HP

1.0-1.5 HP

1.5-2.0 HP

By State

Maharashtra

Tamil Nadu

Gujarat

Karnataka

Telangana

Kerala

Delhi NCR

West Bengal

Madhya Pradesh

Bihar

Other States

By Distribution Channel

Dealer and Distributor Network

Direct Sales Channel

Online Sales Channel

Companies Covered:-

Crompton

Kirloskar

Texmo Industries (Texmo and Taro)

Lubi Pumps

V-Guard

C.R.I. Pumps

Aqua Group (Texmo and Aquatex)

Lagajjar (Varuna Pumps)

Usha Pumps

Havells

KSB Group

Suguna Pumps

Grundfos

Shakti Pumps

CG Power

Mahendra Pumps

Duke

Polycab

Bindhu Pumps

Kumar Pumps

Deccan Industries

ESPA

Key Target Audience:-

Global & Domestic Pump Manufacturers

Pump Distributors

Pump Importers

Government Associations

Electric Consumer Durables Companies

Private Equity and Venture Capitalists firms

Time Period Captured in the Report:-

Historical Period: FY’2015-FY’2020

Forecast Period: FY’2021-FY’2025

Key Topics Covered in the Report:-

Domestic Pump Value Chain Analysis

Domestic Pumps Market Size and Future Projections (FY’2015-FY’2025)

Domestic Pump Market Segmentation by Pump Type, Distribution Channel, Motor Rating and Regional Demand

Residential Landscape of Maharashtra, Delhi NCR, Tamil Nadu, Gujarat, Karnataka

Trends and Developments in Domestic Pump Market

AI in Domestic Pumps Market

Competitive Landscape of Major Players in Global Pumps Market

Strengths and Weakness of Major Players in Domestic Pumps Market

Market Share of Major Players in Domestic Pumps Market

Porter’s Five Force Analysis of Domestic Pump Market

Future Market Trends and Way Forward

Analyst Recommendations

For More Information on the research report, refer to below link:-

India Domestic Pumps (Less than 2.5 HP) Market

Related Reports:-

India Plastic Pipes and Fittings Market Forecast to 2026 - By PVC Pipes (UPVC and CPVC Pipes), by Applications (Irrigation, Sewerage, Water Supply and Plumbing and Borewell Application), by Organized and Unorganized Sector and by Regions

Competition Benchmarking in Global Pumps Market – WILO Group, KSB Group, Xylem Pumps Inc, EBARA Group, Grundfos Group, Sulzer Pumps, Shimadzu Group, Kirloskar Brothers Limited, Flowserve Inc, Weir Group

Competition Benchmarking in Vietnam Pumps Market - HAPUMA, Ebara Vietnam, Grundfos Vietnam, WILO Vietnam, KSB Vietnam, IWAKI Vietnam, TSURUMI Pump Vietnam Company, INTECH Pump, SAIGON Industrial Pump JSC Vietnam

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Profitable Insights of Global Anticoagulant Reversal Drugs Market Outlook: Ken Research

 Anticoagulant drugs are medicines that has application in protection from blood coagulation, accustomed to reverse or balance haemorrhage. It conjointly helpful in prevention of risk related to the anticoagulants that arises due to the overdose of an anticoagulant therapy or unplanned surgery. It additionally prevents from serious conditions like strokes and heart attacks to the person suffering from blood coagulation. The anticoagulant reversal medicines have admirable application in therapy and prognosis of cardiovascular disorder owning to its advent advantages of removing and dissolving blood clots. Additionally, the increase within the prevalence of atrial fibrillation and cardiovascular disease is the issue that is probably likely to spice up this market


According to the study, ‘Global Anticoagulant Reversal Drugs Market to reach USD 2588.11 Million by 2026’ express that there are some corporates which presently working more successfully for dominant the elevated market growth and getting the effective competitive edge whereas adopting the effective profitmaking ways and policies like joint ventures, mergers and acquisitions, partnerships, amalgamation and product development includes CSL Behring Limited, Pfizer Inc, Portola Pharmaceuticals Inc, Boehringer Ingelheim GmbH,  Bausch Health Companies Inc, Amneal Pharmaceuticals Inc, Fresenius Kabi  AG , Octapharma AG, Perosphere Pharmaceuticals Inc .By Drug Class segmented into Prothrombin Complex Concentrates, Phytonadione, Monoclonal Antibodies, Coagulation Factors and several others.

The properties of anticoagulants have resulted in a high product adoption in various industries. The increasing prominence on the critical effects of unattended cardiovascular diseases can fuel the demand for anticoagulants. For illustration: As per the World Health Organization, Cardiovascular diseases are evaluated as the foremost cause of death due to disease around the world which accounts for over 17.9 million, 31% of worldwide deceased every year due to cardiovascular disease. It is estimated that more than 75% of deaths occurred through cardiovascular disease is emerged in low and middle-income countries and over 85% of deaths are taking place due to sever heart attacks and strokes.  However, the high price of patented drugs would deter the expansion of market within the rising economies over the forecast years.

The regional analysis of worldwide Anticoagulant Reversal Drugs market is taken inti account for the key regions like Asia Pacific, North America, Latin America, Europe and Remainder of the World. North America is that the leading/significant region across the world in terms of market share as a result of the rise in cases of disorders within the region. Whereas, Asia-Pacific is additionally anticipated to exhibit highest rate of growth / CAGR over the forecast amount 2020-2026. Factors like the presence of enormous geriatric population within the rising economies of the region would produce profit-making growth prospects for the Anticoagulant Reversal Drugs market across Asia-Pacific region.

Moreover, rise in geriatric population and rises of issues concerning blood clots in the population gave exponential rise within the demand of anticoagulant reversal drugs across the world. Therefore, in the forthcoming period, it is projected that the worldwide market of the anticoagulant reversal drugs will increase around the globe more significantly over the incoming years.

For More Information, Click on the Link Below:-

Global Anticoagulant Reversal Drugs Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Monday, October 5, 2020

Profitable Insights Of Global Clinical Chemistry Analysers Market Outlook: Ken Research

 Buy Now

Clinical chemistry is that the field of clinical pathology that deals with the analysis of body fluids, that square measure useful within the diagnosis and medicine of diseases. The clinical chemistry analyzers square measures use in mechanisms like ion-selective potentiometry, latex agglutination, and photometric & colorimetric testing to research the body fluids (i.e. blood serum, plasma, and urine). They are primarily used for testing the metabolic functions to understand diseases like polygenic disorder and drugs-of-abuse testing. Many sorts of the clinical analyzers are accessed like benchtop analyzers and compact side models, typically with fewer check choices and high-input floor-based units.

According to the study, ‘Global Clinical Chemistry Analyzers Market to reach USD 17,176 million by 2026’ express that there square measure some corporates that presently functioning plenty of successfully for dominant the foremost effective growth of the market and getting the productive competitive edge whereas acceptive the productive profitmaking ways and policies like joint ventures, mergers and acquisitions, partnership, merger, and merchandise the development includes Danaher Corporation, Johnson & Johnson, Siemens AG, Abbott Laboratories, Elitech Group, Horiba, Ltd., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Mindray Medical International Limited. Rising incidences of life-style diseases like polygenic disorder, growing tending expenditure, and increase within the variety of reagent rental agreements are the few elements accountable for high CAGR of the market over the forecast period. Consistent with the International Diabetic Federation (IDF), the number of adults with polygenic the disorder was calculable around 415 million in 2015, and this variety is projected to grow to nearly 578 million by 2030, globally. This, in turn, is predicted to accelerate the demand for Clinical Chemistry Analyzers, therefore causative to the expansion of the world market.


Additionally, dependent on the regional investigation of worldwide Clinical Chemistry Analyzers market is taken into account for the key regions like Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the main country over the world in terms of market share due to the confirming government initiatives for clinical chemistry and high implementation follow tips enacted by tending organizations' gift within the region. Whereas, Asia-Pacific is additionally anticipated to exhibit the highest rate of growth over the forecast period 2020-2026, because of progressively turning into saturated makers and suppliers of clinical chemistry analyzers products within the rising countries like China and India.

Over recent years, the international Clinical chemistry Analyzer market has been witnessing growth, on account of the speedy growing medical specialty market, increase in attention expenditure, increase in lifestyle diseases like polygenic disorder, cardiovascular diseases, growth in the aging population, and increasing demand of laboratory automation. Moreover, chop-chop increasing range of hospitals and medical specialty laboratories because of the billowing prevalence of chronic diseases, cancer, vector-borne diseases, and blood disorders are driving the market growth. Clinical chemistry analyzer square measures the computer-programmed devices utilized for determinant and analyzing the amount of sugar and protein present within the blood. These devices inside the smallest amount of attainable time come back with an accurate result as they need extraordinarily advanced technologies and are designed for such purpose. Furthermore, the presence of favorable government policies and well-developed clinical research infrastructure will propellant the expansion of the market.

For More Information on the Research Report, refer to below links: -

Global Clinical Chemistry Analysers Market

Related Report: –

Global Automated Clinical Chemistry Analyzers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Contact Us: –

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Rise in Prevalence of Diabetic Population Expected to Drive Global Blood Glucose Monitoring System Market: Ken Research

 Blood glucose monitoring system is the type of diagnostics system, used for the care & treatment of diabetes. It is used to measure & monitor the levels of blood sugar in the patients. These systems help in preventing other health-related conditions for instance retinopathy, neuropathy, and cardiovascular diseases. There are numerous types of blood glucose monitoring systems available in the market, which is known as blood glucose meter that are varying in price, size, duration of testing time, and ease of utilization.


According to study, “Global Blood Glucose Monitoring Systems Market to reach USD 17.1 billion by 2026” the key companies operating in the global blood glucose monitoring system market are F. Hoffman-La Roche Ltd., Ascencia Diabetes Care Holdings AG, Abbott Laboratories, Terumo Medical Corporation, Dexcom Inc., B. Braun Melsungen AG, Medtronic, Diamon Tech GmbH, Lifescan Inc. and Nova Biomedical.  Major players are primarily concentrating on research & development (R&D) initiatives and innovative product developments to cater the needs of customers.

Based on product type, blood glucose monitoring system market is segmented as continuous glucose monitoring systems and self-monitoring blood glucose monitoring systems. Continuous glucose monitoring systems include transmitters, sensors and receivers. Continuous glucose monitoring system segment dominates the global market owing to rise in adoption of minimally invasive procedures. Self-monitoring blood glucose monitoring systems include testing strips, blood glucose meters and lancets & lancing devices. Based on testing site, market is segmented as alternate site testing and fingertip testing. Based on patient care setting, market is segmented as hospitals/clinics and self/home care. Self/home care segment is anticipated to witness higher CAGR due to growth in diabetic population, increase in product launches enhancing patient comfort when used at home and rise in awareness about regular monitoring of glucose levels during the forecast period. In addition, based on application, market is segmented as diabetes and others. Diabetes includes Type 1 diabetes, Type 2 diabetes and gestational diabetes.

The blood glucose monitoring system market is driven by rise in prevalence of diabetic population, followed by increase in preference for less invasive technologies and growth in number of product launches. However, inadequate reimbursement and high cost of monitoring systems may impact the market. Moreover, growth in technological advancement in products and surge in online marketing strategies are key opportunities for market.

Based on geography, the North-American region holds major share in global blood glucose monitoring system market owing to favorable reimbursements policies, increase in FDA approvals for these systems & supplies in the region. Whereas, the Asian-Pacific and European regions are anticipated to exhibit highest growth rate due to large number of diabetic patients coupled with rapid economic growth in countries such as China and India over the forecast period.  In upcoming years, it is estimated that future of the global market will be optimistic on account of rise in awareness programs for diabetes owing to its high prevalence during the forecast period. The global blood glucose monitoring systems market is valued approximately at US $10.8 billion in 2019 and is expected to grow with a healthy growth rate of more than 6.8% over the forecast period 2020 to 2026.

For More Information, Click on the Link Below:-

Global Blood Glucose Monitoring Systems Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Rise in Incidence of Neurological Diseases Expected to Drive Global Deep Brain Stimulation Market: Ken Research

 Buy Now

Deep brain stimulation is a surgery that involves the implantation of an electrical device in the body. The device is responsible for sending various electrical signals to the area of the brain, which is responsible for body movement. It is used in the treatment of various neurological disorders such as essential tremor, Parkinson's disease, epilepsy, obsessive-compulsive disorder, dystonia, and others. In addition, the devices are also used to block pain signals by sending an electrical impulse near the spine region.

According to the study, “Global Deep Brain Stimulation Devices Market to reach USD 1.86 billion by 2026” the key companies operating in the global deep brain stimulation devices market are Medtronic Plc., Aleva Neurotherapeutics SA, Boston Scientific Corporation, Beijing PINS Medical Co., Ltd., Abbott laboratories, NeuroPace Inc., Functional Neuromodulation Ltd., Nevro Corporation, Neuronetics Inc., and Cyberonics, Inc. The key market players are focusing on launching novel medical devices, building growth strategies and technological advancements to support their position in the global market.

Based on type, the deep brain stimulation devices market is segmented as Globus Pallidus DBS, Subthalamic DBS, Pedunculopontine Nucleus DBS and Thalamic DBS. Based on product type, the market is segmented as a single-channel deep brain stimulator and dual-channel deep brain stimulator. The dual-channel deep brain stimulation device segment dominates the market owing to higher adoption in surgical procedures. Based on application, the market is segmented as Epilepsy, Pain Management, Depression, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Parkinson’s disease, Dystonia, and others. In addition, based on end-use, the market is segmented as neurology clinics, hospitals, research centers, and ambulatory surgical centers. The hospital's segment is expected to witness a higher growth rate due to an increase in the number of deep brain stimulation surgeries and a rise in the use of technologically advanced deep brain stimulation devices in operation theaters & intensive care units during the forecast period.


The deep brain stimulation devices market is driven by rising in the incidence of neurological diseases, followed by an increase in preferences for a targeted therapy approach, growth in technological advancements. However, risks associated with deep brain stimulation procedures and stringent regulatory frameworks may impact the market. Moreover, alternative use of deep brain stimulators is a key opportunity for the market.

Based on geography, the North-American region holds a major share in the global deep brain stimulation devices market owing to wide availability of technologically advanced deep brain stimulation devices in the region. Whereas, the European and Asian-Pacific regions are anticipated to witness higher growth rate due to the rise in prevalence of neurodegenerative disorders aided with unmet demand for effective & long-term solutions over the forecast period. In upcoming years, it is anticipated that the future of the global market will be bright as a result of an increase in the number of patients diagnosed with Parkinson during the forecast period. The global deep brain stimulation devises market is valued approximately at the US $0.9 billion in 2018 and is predictable to grow with a healthy growth rate of more than 9.5% over the forecast period 2019 to 2026.

For More Information on the Research Report, refer to below links: -

Global Deep Brain Stimulation Devices Market

Related Report: –

Global Deep Brain Stimulation Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Contact Us: –

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Dissimilar Trends And Developments Across Global Autoimmune Disease Diagnostics Market Outlook: Ken Research

The Autoimmune diseases consult with body's abnormal immunological response leading to the assembly of antibodies that impact or attack own cells & tissues that ends up in destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases like systematic lupus erythematosus and rheumatoid arthritis current within the world state of affairs. 

According to the study, ‘Global Autoimmune Disease Diagnostics Market to reach USD 7.5 billion by 2026express that there are some corporates that presently functioning actively for being successful and for dominating the foremost effective growth of the market and getting the productive competitive edge whereas acceptance of the productive profit making ways and policies like joint ventures, mergers and acquisitions, partnership, merger and merchandise development includes Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Inc., Grifols, Siemens Healthineers, Trinity Biotech, Exagen Inc., HYCOR Biomedical, Werfen For instance: in keeping with the American Autoimmune Related Diseases Association (AARDA), the autoimmune disorder impacts around 50 million peoples residing in each urban and semi-urban provinces among which 75% are females within the United States leading to supply the demand and adoption of autoimmune disease medical specialty market. However, high capital needs impede the expansion of the market over the forecast period of 2020-2026.

As per the American Autoimmune Related Diseases Association, around 50 million Americans presently suffer from autoimmune connected disorders. Moreover, the numbers area unit expected to intensify over the forecast period. The demand for higher and precise diagnostic strategies, beside the increasing prevalence, is predicted to extend over the forecast period. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases like rheumatoid arthritis, Hashimoto's inflammation, and presence of favourable government rules can render vital impact on the autoimmune disorder medical specialty market growth.

The regional investigation of worldwide Autoimmune Disease Diagnostics market is taken into account for the key regions like Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is that the main country over the world in terms of market share thanks to the high incidence & prevalence of autoimmune diseases and growth in variety of analysis activities on autoimmune diseases. Whereas, Asia-Pacific is additionally anticipated to exhibit highest rate of growth over the forecast period 2020-2026. Factors like rising aging population beside use of biosensors for autoimmune disorder designation would produce remunerative growth prospects for the Autoimmune Disease Diagnostics market over Asia-Pacific region.

Furthermore, the Auto immune disease diagnostics market will be increase in upcoming years. The key factors dynamic the market embrace the growing public awareness of autoimmune disease, rising laboratory automation, partnerships with physicians and clinical laboratories, technological advancements, enlargement in coverage allowed by the Patient Protection and Reasonable Care Act. The market primarily driven because of high prevalence of autoimmune diseases, escalating awareness, concerning autoimmune diseases, rise within the range of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key consider the event growth of autoimmune disease diagnostics market.

For More Information refer to below link:-

Global Autoimmune Disease Diagnostics Market

Related Report:-

Autoimmune Disease Diagnostics Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Contact Us: -
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Dissimilar Trends and Developments across Global Neurotrophic Keratitis Market Outlook: Ken Research

 Neurotrophic Keratitis (NK) could be a neurodegenerative sickness caused by the injury of trigeminus nerve that affects the membrane of an eye fixed. During this sickness, the patient drops the membrane sensitivity and so membrane is unprotected to damages while not treatment. If this sickness is not treated and diagnosed properly, the patient will loss permanent eye vision. The treatment of neurotrophic keratitis is finished by a team that has neurologists, ophthalmologists and corneal specialists. Treatments are accessible supported the severity of the sickness. Neurotrophic Keratitis treatment contains topical antibiotics, bandage contact lenses, preservative artificial tears, amniotic membrane transplantation, organ transplant, Recombinant human nerve growth factor (rhNGF), and so on.


According to the study, ‘Global Neurotrophic Keratitis Market to reach USD 276 million by 2026’ categorical that there are some corporates that presently functioning additional with success for dominant the most effective growth of the market and obtaining the productive competitive edge whereas acceptive the productive profitmaking ways and policies like joint ventures, mergers and acquisitions, partnership, merger and merchandise development includes Bayer AG, Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Allergan, Plc., ReGenTree, LLC., Cooper Vision, Dompe farmaceutici S.p.A., Novartis AG, Johnson & Johnson, Walgreens. Growing range of approvals for brand new product innovation from restrictive authorities, with the massive support to the researchers for developing novel treatments are the few factors chargeable for high growth rate of the market over the forecast period. While, low healthcare budget in number of the developing countries is one among the most important factors expected to hamper the expansion of the market over the forecast period of 2020-2026.

The regional investigation of worldwide Neurotrophic Keratitis market is taken into account for the key regions like Asia Pacific, North America, Europe, Latin America and remainder of the globe. North America is the main country over the world in terms of market share attributable to the rising product approvals, presence of well-established health care infrastructure, and increase in R&D activities in neurotrophic keratitis within the country. Whereas, Asia-Pacific is additionally anticipated to exhibit highest rate of growth/ CAGR over the forecast period 2020-2026, thanks to growing geriatric population and increasing government investments in health care and R&D gift within the countries like China and India.

During the present era, numerous organizations across industries have offices around the globe. For example, in August 2018, Dompe farmaceutici S.p.A. has received approval for cenegermin topical eyes drop from the Food and Drug Administration that could be a recombinant human nerve expansion factor for the therapy of neurotrophic keratitis. The cenegermin has additionally obtained an Orphan Drug designation, Breakthrough medical aid designation and means standing from the Food and Drug Administration. This, in turn, is anticipated to accelerate the expansion of Neurotrophic Keratitis market around the world. Therefore, in the near years, it is anticipated that the market Neurotrophic Keratitis Market will increase globally over the coming decades more proficiently.

For More Information, Click on the Link Below:-

Global Neurotrophic Keratitis Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Hectic Work Schedules among Working Individuals Expected to Drive Global Nutrition & Supplements Market: Ken Research

 Buy Now

Nutritional supplements are destined to supplement the diet, which is extracted from either food source or synthetic & animals. It is intended to intake in capsule or tablet and liquid forms, which are taken by mouth with an intention to supplements the diet of an individual. These supplements include protein, vitamin, minerals, and amino acid among other nutritional substances that may not be consumed with a regular diet. All the minerals & vitamins are required for healthy skin, hair, and nails. Due to such advantages, they are helpful in reducing extra calories & weight; consequently, growing awareness among people regarding health awareness is anticipated to drive the growth of the market over the forecast years. However, such products often include large doses of vitamins & minerals which may cause side effects such as diarrhea, constipation, and other stomach problems.

According to the study, “Global Nutrition & Supplements Market to reach USD 214.04 billion by 2026” the key companies operating in the global nutrition & supplements market are Pfizer Inc., Glaxosmithkline PLC, Amway, Abbott Laboratories, Suntory Holdings Ltd., Otsuka Holdings Co. Ltd., Glanbia PLC, Bayer AG, DuPont, and Sanofi S.A.

Based on type, the market is segmented as botanicals, vitamins, amino acids, minerals, protein, fatty acids, enzymes, and others. Based on function, the market is segmented as a medicinal supplement, additional supplement, and sports nutrition. Based on category, the market is segmented as children's dietary supplements, infant dietary supplements, pregnant women dietary supplements, adult dietary supplements, old-aged dietary supplements, and others. In addition, based on the distribution channel, the market is segmented as pharmacy stores, hypermarket & supermarket, online channels, and others.


The market is driven by rising alertness among gym professionals & athletes towards calories reduction, followed by growth in awareness towards functional food and an increase in urbanization. However, volatility in raw material prices and stringent rules & regulations for dietary supplements may impact the market. Moreover, growth in technological advancement in manufacturing techniques which may include 3D Printing and collaboration & tie-up of leading players are key opportunities for the market. Furthermore, the rise in relevance for the preventive healthcare system, growth in innovation in terms of the introduction of nutraceutical products, and lifestyle enhancement products are major trends for the market.

Based on geography, the North-American region is the leading region in the global market owing to the rise in awareness among people regarding health management in the region. Whereas, the Asian-Pacific and European regions are expected to witness higher growth rate due to hectic work schedules among working individuals along with fluctuations in diet intervals over the forecast period. In the upcoming years, it is estimated that the future of the global market will be optimistic as a result of an increase in awareness about the health benefits of nutritional supplements during the forecast period. The global nutrition & supplements market is valued approximately at US $113.94 billion in 2019 and is expected to grow with a healthy growth rate of more than 8.2 % over the forecast period 2019 to 2026.

For More Information on the Research Report, refer to below links: -

Global Nutrition & Supplements Market

Related Report: –

Sports Nutrition Market (Sports Food, Sports Drink & Sports Supplements): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Contact Us: –

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Rise in Incidence of Breast Cancer Expected to Drive Global Breast Cancer Diagnostics Market: Ken Research

The breast cancer is characterized by malignant tumor formed in the breast cells that can spread to other parts of the body. It is observed in females. Breast cancer is diagnosed at early stages by certain screening tests like yearly mammograms, MRI and CT scans. Symptoms of breast cancer include a change in the shape of breast, skin dimpling, and fluid leakage from the nipple, lump in a breast, patches on the skin, etc. Once the symptoms are detectable, an individual is advised to endure a diagnostic test to confirm the suspect of breast cancer. These diagnostic tests are carried out by biopsy in which a little amount of internal tissue is removed from the patient’s body & observed under the microscope to diagnose breast cancer. This method of diagnostic can be carried out with the help of various diagnostic options such as biopsy, clinical lab tests and ultrasound techniques that are available in the breast cancer diagnostic market. Additionally, breast cancer can be developed in normal individuals due to several risk factors that involve alcohol consumption, menopause, low physical exertion, obesity, family history and delivering a child at an older age.

According to study, Global Breast Cancer Diagnostics Market to reach USD 8.5 billion by 2026 the key companies operating in the global breast cancer diagnostics market are Hologic Inc., Aurora Imaging Technology Inc., GE Healthcare, Fujifilm Holdings Corporation, Phillips Healthcare, Dilion Technologies Inc., Gamma Medica Inc., Genomic Health, Toshiba Corporation and NanoString Technologies, Inc. The leading players are implementing different business strategies for instance product development, new product launches, and research & development (R&D) activities. Companies also engage in business collaborations to commercialize their product in different countries to expand greater market share.

Based on diagnostic type, breast cancer diagnostics market is segmented as ionizing breast imaging technologies and, non-ionizing breast imaging technologies. Ionizing breast imaging technologies include analog mammography, 3D breast tomosynthesis, ionizing breast imaging technologies, Full-field digital mammography (FFDM), Positron emission tomography/ Computed tomography (PET/CT), Molecular Breast imaging/ breast specific gamma imaging (MBI/BSMI) and others. Non-ionizing imaging technologies include breast ultrasound, Breast MRI (Magnetic Resonance Imaging), Automated Whole Breast Ultrasound (AWBU), breast ultrasound, breast thermography and optical imaging. In addition, based on end-user, market is segmented as diagnostic clinical laboratories, hospitals, ambulatory surgical centers and cancer research centers/ institutes.

The breast cancer diagnostics market is driven by increase in number of breast cancer screening programs, followed by rise in incidence of breast cancer and favorable reimbursement framework for breast cancer diagnosis. However, increase in regulatory issues, high installation cost of devices and side effects of radiation may impact the market.

Based on geography, the North-American region holds major share in global breast cancer diagnostics market owing to high patient awareness and early adoption of technologically advanced imaging systems in the region. Whereas, the European and Asian-Pacific regions are estimated to witness higher growth rate due to increase in incidence of breast cancer coupled with rapidly improving healthcare infrastructure over the forecast period. In upcoming years, it is predicted that future of the global market will be optimistic as a result of well-established diagnostic infrastructure during the forecast period. The global breast cancer diagnostics market is valued approximately US $5.0 billion in 2019 and is estimated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020 to 2026.

For More Information refer to below link:-

Global Breast Cancer Diagnostics Market

Contact Us: -
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Rise in Ownership of Pets Expected to Drive Global Pet Food Packaging Market: Ken Research

The Pet food packaging is used for wrapping & enclosing food items, produced specially for pets (animals). The packaging of such product is available in flexible, rigid and semi-rigid options. Quality of life & health of pets mainly depends on their diet. Majority of pet lovers and pet owners concerned about proper nutrition of pets for such purpose animals/pet packaging is necessary to assure good quality of food. The market is anticipated to increase over the forecast year owing to increasing adoption of pets over the forecast years.

According to study, Global Pet Food Packaging Market to reach USD 12.53 billion by 2026 the key companies operating in the global pet food packaging market are Amcor PLC, Sonoco products company, Mondi PLC, Huhtamaki OYJ, Constantia Flexibles, Smurfit Kappa, Berry global group, Inc., Aptargroup, Inc., Ardagh group S.A. and Goglio S.P.A.

Based on type of packaging, pet food packaging market is segmented as flexible packaging and rigid packaging. Flexible packaging is further sub-segmented as bag packaging, pouch packaging and others. Pouch segment holds major share in global market owing to rise in demand by various pet food brands. Rigid packaging is further sub-segmented as boxes packaging, cartons packaging, bottles packaging and other packaging. Pouches segment is projected to grow at the highest CAGR during the forecast period, in terms of value as well as volume. Based on material, market is segmented as paper & paperboard, plastic, metal and others materials (glass and woven materials). Plastic packaging material segment is expected to witness higher growth rate as it is durable, cost-effective, lightweight, and versatile nature during the forecast period. Based on animal type, market is segmented as cat food, dog food, fish food, bird food and others (rabbit, reptiles, guinea pigs and tortoise). In addition, based on food type, market is segmented as wet food, pet treats, dry food and others (frozen, chilled and freeze dried).

The pet food packaging market is driven by rise in pet food expenditure, followed by growth in pet ownership, humanization of pet food and convenience, simplicity and product differentiation with transparency in pet food packaging. However, shortage of raw material & fluctuation in their prices and stringent pet food quality & safety regulations may impact the market. Moreover, countries with emerging economies and e-commerce & online delivery channels are key opportunities for market. Furthermore, collaboration & tie-up of leading players and value oriented consumers are major trend for market.

Based on geography, the North-American region is a leading region in global pet food packaging market owing to rise in ownership of pets in the region. Whereas, the Asian-Pacific and European regions are estimated to witness higher growth rate due to growth in expenditure in pet food along with humanization of pet food during the forecast period. The global pet food packaging market is valued approximately at US $9.79 billion in 2019 and is projected to grow with a healthy growth rate of more than 4.20% over the forecast period 2019 to 2026.

For More Information refer to below link:-

Global Pet Food Packaging Market

Related Report:-

World Pet Food Packaging Market Research Report 2024 (covering USA, Europe, China, Japan, India, South East Asia and etc)

Contact Us: -
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249